Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2010
11/25/2010US20100299778 Nucleotide sequence encoding artemisinic aldehyde double bond reductase, artemisinic aldehyde double bond reductase and uses thereof
11/25/2010US20100299770 Targeted cell death
11/25/2010US20100299769 Novel peptide involved in energy homeostasis
11/25/2010US20100299768 Reversible siRNA-Based Silencing of Mutant and Endogenous Wild-Type Huntingtin Gene and its Application for the Treatment of Huntington's Disease
11/25/2010US20100298553 Cot102 insecticidal cotton
11/25/2010US20100298552 Emulsion compositions
11/25/2010US20100298551 Methods Of Producing And Sequencing Modified Polynucleotides
11/25/2010US20100298545 EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
11/25/2010US20100298417 Modulation of factor 7 expression
11/25/2010US20100298415 Targeted schiff base complexes
11/25/2010US20100298411 Lipid-modified double-stranded rna having potent rna interference effect
11/25/2010US20100298410 MICROMIRs
11/25/2010US20100298409 Compositions comprising stat3 sirna and methods of use thereof
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100298407 Compositions and methods featuring micronas for treating neoplasia
11/25/2010US20100298405 Compositions And Methods For Inhibiting Expression Of Huntingtin Gene
11/25/2010US20100298404 Translocation and mutant ROS kinase in human non-small cell lung carcinoma
11/25/2010US20100298239 Peptide with multiple epitopes
11/25/2010US20100298238 Nontoxic shiga-like toxin mutant compositions and methods
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298232 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
11/25/2010US20100298226 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
11/25/2010US20100298224 Use of mutated antithrombins for treating or preventing coagulation disorders
11/25/2010US20100298220 Fibroblast growth factor mutants having improved functional half-life and methods of their use
11/25/2010US20100298213 Pharmaceutically Active Insulin Receptor-Modulating Molecules
11/25/2010US20100298203 Sdf-i-based glycosaminoglycan antagonists and methods of using same
11/25/2010US20100298170 Methods and systems for introducing functional polynucleotides into a target polynucleotide
11/25/2010US20100298166 Cell populations for polypeptide analysis and uses of same
11/25/2010US20100298165 Bioarray chip reaction apparatus and its manufacture
11/25/2010US20100298152 Use of aptamers in proteomics
11/25/2010US20100298151 Exosome-associated microrna as a diagnostic marker
11/25/2010US20100298146 S-adenosylmethionine synthetase expression elements identified from arabidopsis thaliana
11/25/2010US20100297769 Centromere sequences and minichromosomes
11/25/2010US20100297751 Non-Ribosomal Peptide Synthetases
11/25/2010US20100297750 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
11/25/2010US20100297738 Expression system
11/25/2010US20100297733 Systems And Methods For The Capture And Separation Of Microparticles
11/25/2010US20100297729 Process for producing transglutaminase
11/25/2010US20100297723 Heat-stable carbonic anhydrases and their use
11/25/2010US20100297721 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof
11/25/2010US20100297713 Mutant delta-8 desaturase genes engineered by targeted mutagenesis and their use in making polyunsaturated fatty acids
11/25/2010US20100297712 Hydroxylase gene and use thereof
11/25/2010US20100297710 Methods and compositions for the extraction and amplification of nucleic acid from a sample
11/25/2010US20100297708 Molecular diagnostics system and methods
11/25/2010US20100297706 Mutant dna polymerases and their genes from thermococcus
11/25/2010US20100297703 Lytic Enzyme Inhibitor, Lysis Inhibitor, Inhibitor of Poly-y-glutamic Acid Degradation, and Method for Producing Poly- y-glutamic Acid
11/25/2010US20100297702 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
11/25/2010US20100297700 Antibodies to TNF Alpha
11/25/2010US20100297699 Nucleic Acids Encoding Humanized Immunoglobulin That Binds Alpha4Beta7 Integrin
11/25/2010US20100297695 Nucleic Acids Encoding Chimeric CD154 Polypeptides
11/25/2010US20100297694 Novel gene from hancenula polymorpha capable of controlling unfolded protein response and method for increasing effect of secretion using the same
11/25/2010US20100297674 NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM
11/25/2010US20100297668 Human e3alpha ubiquitin ligase family
11/25/2010US20100297664 Paratope and epitope of anti-mortalin antibody
11/25/2010US20100297662 Antibody and use thereof
11/25/2010US20100297641 Methylation altered dna sequences as markers associated with human cancer
11/25/2010US20100297637 Primer for amplification of rrna or bacterium belonging to the genus legionella, detection method, and detection kit
11/25/2010US20100297636 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
11/25/2010US20100297629 Nucleic acid supported protein complementation
11/25/2010US20100297624 Involvement of Lipid Kinase, and Signal Transduction Pathway Comprising Said Lipid Kinase, in Resistance to HER2-Targeting Therapy
11/25/2010US20100297623 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
11/25/2010US20100297617 Primer set for amplifying nat2 gene, reagent for amplifying nat2 gene containing the same, and the uses thereof
11/25/2010US20100297615 Egfr mutations
11/25/2010US20100297613 Nucleic acid, amino acid encoded by said nucleic acid, probe comprising said nucleic acid or said amino acid, and screening method using said probe
11/25/2010US20100297612 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus
11/25/2010US20100297606 IgG BINDING PEPTIDE
11/25/2010US20100297605 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c
11/25/2010US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing
11/25/2010US20100297187 Peptide sequences and compositions
11/25/2010US20100297178 Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
11/25/2010US20100297177 Mutated parvovirus structural proteins as vaccines
11/25/2010US20100297174 Influenza virus vaccines and uses thereof
11/25/2010US20100297169 Novel Neutralizing Immunogen (NIMIV) of Rhinovirus and its Use for Vaccine Applications
11/25/2010US20100297153 Binding molecules for treatment and detection of cancer
11/25/2010US20100297152 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/25/2010US20100297151 Antibodies against human il-21 receptor and uses therefor
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297144 Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection
11/25/2010US20100297138 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
11/25/2010US20100297136 Gastric and Prostate Cancer Associated Antigens
11/25/2010US20100297131 Binding domain of plasmodium reticulocyte binding proteins
11/25/2010US20100297130 Protective anti-glucan antibodies with preference for beta-1,3-glucans
11/25/2010US20100297124 Induced internalization of surface receptors
11/25/2010US20100297119 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/25/2010US20100297111 Nanobodies against tumor necrosis factor-alpha
11/25/2010US20100297109 Methods for inhibiting fascin
11/25/2010US20100297103 Antibody having enhanced adcc activity and method for production thereof
11/25/2010US20100297101 Integrin alpha. II .B.beta.3 Specific Antibodies and Peptides
11/25/2010US20100297093 Modified t cell receptors and related materials and methods
11/25/2010US20100297091 Compositions and methods for treatment of melanomas
11/25/2010US20100297083 Polynucleotides and Polypeptide of Human KV1.3, Compositions Comprising Same and Methods of Using Same
11/25/2010US20100297076 Targeted interferon demonstrates potent apoptotic and anti-tumor activities
11/25/2010US20100297070 COMPOSITIONS AND METHODS FOR AMELIORATING CNS INFLAMMATION, PSYCHOSIS, DELIRIUM, PTSD or PTSS
11/25/2010US20100297024 Promoter inducible by reactive oxygen species and vector comprising the same
11/25/2010US20100297014 Method of detecting the risk of cancer using genetic markers
11/25/2010US20100297011 Isolated peptides and uses thereof
11/25/2010US20100297003 Anti-human tenascin monoclonal antibody
11/25/2010CA2799995A1 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus
11/25/2010CA2763283A1 Phytases, nucleic acids encoding them and methods for making and using them
11/25/2010CA2763016A1 Targeting micrornas for metabolic disorders
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 899